Skip to main content
Top

Infection

Issue 2/2006

Content (14 Articles)

Clinical and Epidemiological Study

Evaluation of Safety and Efficacy of Rosiglitazone in the Treatment of HIV-Associated Lipodystrophy Syndrome

T. Feldt, M. Oette, A. Kroidl, K. Goebels, R. Fritzen, J. Kambergs, G. Kappert, C. Vogt, M. Wettstein, D. Häussinger

Clinical and Epidemiological Study

Evolution of Hepatitis C Virus Quasispecies in Children with Chronic Hepatitis C

M. Gerotto, M. Resti, F. Dal Pero, I. Migliorato, A. Alberti, F. Bortolotti

Clinical and Epidemiological Study

Assessment of the Clinical Significance of Production of Extended-spectrum β-Lactamases (ESBL) by Enterobacteriaceae

R. Henshke-Bar-Meir, A. M. Yinnon, B. Rudensky, D. Attias, Y. Schlesinger, D. Raveh

Clinical and Epidemiological Study

Fever of Unknown Origin in Taiwan

C. Chin, Y.-S. Chen, S. S.-J. Lee, S.-R. Wann, H.-H. Lin, W.-R. Lin, C.-K. Huang, H. C. Tsai, C. H. Kao, M.-Y. Yen, Y.-C. Liu

Experimental Study

In Vitro Inhibition of Coagulase-Negative Staphylococci by Vancomycin/Aminoglycoside-Loaded Cement Spacers

J. C. Streuli, G. U. Exner, C. L. Reize, C. Merkofer, C. P. Scott, R. Zbinden

Brief Report

Evaluation of S. aureus ID, a Chromogenic Agar Medium for the Detection of Staphylococcus aureus

B. M. W. Diederen, C. M. van Leest, I. van Duijn, P. Willemse, P. H. J. van Keulen, J. A. J. W. Kluytmans

Case Report

Necrotizing Gastritis due to Bacillus cereus in an Immunocompromised Patient

J. Le Scanff, I. Mohammedi, A. Thiebaut, O. Martin, L. Argaud, D. Robert

Case Report

Neuroborreliosis in an HIV-1 Positive Patient

R. Černý, L. Machala, M. Bojar, H. Rozsypal, D. Pícha

Correspondence

Seroprevalence of Antibodies to Anaplasma phagocytophilum in Antalya, Turkey

G. Ongut, D. Ogunc, G. Mutlu, D. Colak, M. Gultekın, F. Gunseren, L. Donmez, D. Tuncer

What’s New in HIV/AIDS

Serious Doubts on Safety and Efficacy of CCR5 Antagonists

S. Horster, F. D Goebel

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.